Table II.
Age | ||||
---|---|---|---|---|
N Stage | Male | Female | χ2 value | P-value |
CTC Positive | 30 | 29 | – | – |
CTC Negative | 5 | 5 | – | – |
Total | 35 | 34 | – | – |
Positivity rate | 85.71% | 85.29% | 2.004 | >0.05 |
CTC, circulating tumor cells; NSCLC, non-small cell lung cancer.
Age | ||||
---|---|---|---|---|
N Stage | Male | Female | χ2 value | P-value |
CTC Positive | 30 | 29 | – | – |
CTC Negative | 5 | 5 | – | – |
Total | 35 | 34 | – | – |
Positivity rate | 85.71% | 85.29% | 2.004 | >0.05 |
CTC, circulating tumor cells; NSCLC, non-small cell lung cancer.